Constellium SE (FRA:3OK) Research & Development: €44 Mil (TTM As of Mar. 2026)


FRA:3OK Constellium SE FRA:3OK
71 GF Score
Price €28.40
GF Value €16.91
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Constellium SE Research & Development?

Constellium SE FRA:3OK -1.39% 71 Research & Development is €44 Mil as of Mar. 2026. GuruFocus rates FRA:3OK with a GF Score™ of 71/100 and a GF Value™ of €16.91 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Constellium SE's Research & Development for the three months ended in Mar. 2026 was €11 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €44 Mil.

Constellium SE  (FRA:3OK) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Constellium SE Research & Development Related Terms

Constellium SE Research & Development Historical Data

* Premium members only.

The historical data trend for Constellium SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Constellium SE Research & Development Chart

Constellium SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.08 43.42 47.68 46.80 43.55

Constellium SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.03 10.40 10.22 11.96 11.25
FRA:3OK
71GF Score
Constellium SE FRA:3OK
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Constellium SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €44 Mil mean?
Constellium SE (FRA:3OK) has a Research & Development of €44 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Constellium SE and its competitors.
Is Constellium SE's Research & Development too high?
Constellium SE's current Research & Development is €44 Mil. Overall, Constellium SE has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Constellium SE's Research & Development compare to KALU and CENX?
Constellium SE's Research & Development of €44 Mil can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Metals & Mining company?
A good Research & Development depends on the Metals & Mining industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Constellium SE and its competitors. Constellium SE's current Research & Development is €44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Constellium SE stock overvalued right now?
Based on GuruFocus' analysis, Constellium SE (FRA:3OK) is currently considered Significantly Overvalued. The stock's GF Value™ is €16.91, compared to a current price of €28.40 — trading 67.9% above its estimated fair value. The current Research & Development is €44 Mil. Constellium SE's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Constellium SE (FRA:3OK), the current Research & Development is €44 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Constellium SE (FRA:3OK) Overvalued in 2026?

Based on GuruFocus' analysis, Constellium SE stock appears to be overvalued. The current stock price of €28.40 is trading 67.9% above its estimated GF Value™ of €16.91. GuruFocus considers Constellium SE to be Significantly Overvalued.

Key valuation signals for FRA:3OK:

  • Research & Development: €44 Mil
  • GF Value™: €16.91 vs. price of €28.40 (67.9% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the FRA:3OK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Constellium SE Business Description

Other Exchanges CSTM:USA3OK:Germany
Address 300 East Lombard Street, Suite 1710, Baltimore, MD, USA, 21202
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.
71GF Score

Get the complete analysis for FRA:3OK

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.40
Price
€16.91
GF Value